Table 3. Clinical and follow-up data of 26 patients with pulmonary mucoepidermoid carcinoma.
| Number (%) | Number (%) | ||
|---|---|---|---|
| Age, yr | Lobe and segmental bronchus | 16(72.7) | |
| Mean | 46.5 | Upper right | 2(12.5) |
| Range | 12–79 | Middle right | 3(18.75) |
| Gender | Lower right | 2(12.5) | |
| Female | 13(50) | Upper left | 3(18.75) |
| Male | 13(50) | Lower left | 6(37.5) |
| Smoking | Within lung | 4(15.4) | |
| Never | 19(73.1) | Upper right | 1(25) |
| Have smoked | 7(26.9) | Lower right | 2(50) |
| Symptoms | Lower left | 1(25) | |
| Present | 22(84.6) | Operation method | |
| Cough | 15(68.2) | Resection | 23(88.5) |
| Hemoptysis | 11(50) | Lobectomy | 17(73.9) |
| Dyspnea | 7(30.4) | Wedge resection | 1(4.3) |
| Chest pain | 2(9.1) | Partial tumor resection | 2(8.7) |
| Fever | 1(4.5) | Tracheal or bronchial segmental resection | 3(13.1) |
| Hoarseness | 1(4.5) | Biopsy | 3(11.5) |
| Absent | 4(15.4) | Radiotherapy and/or Chemotherapy(n = 23) | |
| Duration symptom, mo | Received | 9(39.1) | |
| Median | 5.5 | Radiotherapy | 4(44.5) |
| Range | 0.5–20 | Chemotherapy | 3(33.3) |
| Pulmonary function testing (n = 20) | Both | 2(22.2) | |
| Restrictive | 1(5) | None | 14(60.9) |
| Obstructive | 2(10) | Follow-up time. mo(n = 23) | |
| Mixed | 0 | Mean | 32.6 |
| Normal | 17(85) | Range | 7–170 |
| Bronchoscopy (n = 16) | Prognosis (n = 23) | ||
| Neoplasm in lumen | 16(100) | Survival | 19(82.6) |
| Normal | 0 | Disease free | 18(94.7) |
| Location (n = 23) | Survival with tumor | 1(5.3) | |
| Trachea or bronchus | 22(84.6) | Death | 4(17.3) |
| Trachea | 4(18.2) | Metastasis (n = 3) | |
| Main bronchus | 2(9.1) | Brain | 1 |
| Left | 1(50) | Bone | 2 |
| Right | 1(50) | Adrenal gland | 1 |